Stocks and Investing Stocks and Investing
Tue, June 11, 2013
Mon, June 10, 2013
Fri, June 7, 2013
Thu, June 6, 2013
Wed, June 5, 2013
Tue, June 4, 2013
Mon, June 3, 2013

Andrew Peters Upgraded (BMRN) to Strong Buy and Held Target at $75 on, Jun 3rd, 2013


Published on 2024-10-25 02:44:57 -
  Print publication without navigation


Andrew Peters of Deutsche Bank, Upgraded "BioMarin Pharmaceutical Inc." (BMRN) to Strong Buy and Held Target at $75 on, Jun 3rd, 2013.

Andrew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $70 on, Wednesday, March 20th, 2013
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $71 on, Tuesday, February 12th, 2013